Exicure to Present Data at the American Association for Cancer Research (AACR) 2018 Annual Meeting

08:00 EDT 16 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Exicure, Inc., the pioneer in gene regulatory and immunotherapeutic drugs utilizing three-dimensional, spherical nucleic acid (SNA™) constructs, announced today that it will present preclinical data in a poster session at the ...

Other Sources for this Article

Exicure, Inc.
Karen Sharma, 781-235-3060


More From BioPortfolio on "Exicure to Present Data at the American Association for Cancer Research (AACR) 2018 Annual Meeting"

Quick Search


Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...